Affiliated Investigators
April Kimmel

April Kimmel

Assistant Professor Virginia Commonwealth University

Learn More

PhD, Health Policy
Harvard University

SM, Population and International Health
Harvard University

AB, History
Dartmouth College

Publications
Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. July 2019
Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: A consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). January 2019
Mathematical modelling to inform ‘treat all’ implementation in sub-Saharan Africa: A scoping review. November 2018
Implementing parallel spreadsheet models for health policy decisions: The impact of unintentional errors on model projections. March 2018
HIV prevention resources: Time to move toward affordability. February 2017
Clinical outcomes of HIV care delivery models in the US: A systematic review. October 2016
Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settings. February 2015
Home HIV testing and counselling: Answers raising questions. November 2014
Lives saved by expanding HIV treatment availability in resource-limited settings: The example of Haiti. June 2013
Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. September 2012
Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: A qualitative assessment. February 2012
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: Modeling clinical outcomes in infants and mothers. June 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: A cost-effectiveness analysis of the OCTANE trial. February 2011
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. February 2011
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. September 2010
Assessing the performance of a computer-based policy model of HIV and AIDS. September 2010
Test and treat DC: Forecasting the impact of a comprehensive HIV strategy in Washington DC. August 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: Clinical benefits and cost-effectiveness. July 2010
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d’Ivoire appraisal. October 2009
When to start antiretroviral therapy in resource-limited settings. August 2009
Scaling up antiretroviral therapy in South Africa: The impact of speed on survival. May 2008
Cost-effectiveness of HIV treatment in resource-poor settings–the case of Côte d’Ivoire. September 2006
Diagnostic tests in HIV management: A review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries. July 2006
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. May 2005
Routine human immunodeficiency virus testing: An economic evaluation of current guidelines. March 2005
Expanded screening for HIV in the United States–an analysis of cost-effectiveness. February 2005
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. January 2005
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. December 2003
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy. December 2002
Treatment for primary HIV infection: Projecting outcomes of immediate, interrupted, or delayed therapy. September 2002
The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality. August 2002
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: Using simulation modeling to inform clinical guidelines. April 2002
Show in Publication Search